0 NASDAQ Companies - June 27, 2019Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled IL-12 with Libtayo® (cemiplimab-rwlc) to Treat Patients with Recurrent GlioblastomaRead More
0 NASDAQ Companies - June 27, 2019Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent DevelopmentsRead More
0 NASDAQ Companies - June 27, 2019Icahn Enterprises L.P. Announces Closing of $500 Million Senior Notes OfferingRead More
0 NASDAQ Companies - June 27, 2019Grindrod Shipping Holdings Ltd. Announces Further Extension of IVS Bulk JV, Fleet Updates and New Funding OpportunitiesRead More
0 NASDAQ Companies - June 27, 2019PFSweb Announces Results of 2019 Annual Meeting of StockholdersRead More
0 NASDAQ Companies - June 27, 2019LPL Financial Announces Second Quarter 2019 Earnings Release Date and Conference CallRead More
0 NASDAQ Companies - June 27, 2019Exponent to Announce Second Quarter of Fiscal Year 2019 Results and Host Quarterly Conference Call on July 18Read More
0 NASDAQ Companies - June 27, 2019SMART Global Holdings Reports Third Quarter Fiscal 2019 Financial ResultsRead More
0 NASDAQ Companies - June 27, 2019Werner Enterprises to Announce Second Quarter 2019 Earnings and Host Earnings Call on July 25Read More
0 NASDAQ Companies - June 27, 2019Chiasma Provides Update on Ongoing Mycapssa® Phase 3 Clinical TrialsRead More
